(Reuters) – The U.S. Food and Drug Administration said on Monday it had revoked the emergency use authorization for five COVID-19 treatments, including those from Eli Lilly and Regeneron.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Krishna Chandra Eluri)